[go: up one dir, main page]

JPS6452723A - Suppressant against multiplication of aids virus - Google Patents

Suppressant against multiplication of aids virus

Info

Publication number
JPS6452723A
JPS6452723A JP21118187A JP21118187A JPS6452723A JP S6452723 A JPS6452723 A JP S6452723A JP 21118187 A JP21118187 A JP 21118187A JP 21118187 A JP21118187 A JP 21118187A JP S6452723 A JPS6452723 A JP S6452723A
Authority
JP
Japan
Prior art keywords
mannan
yeast
aids virus
multiplication
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP21118187A
Other languages
Japanese (ja)
Inventor
Masahiko Ito
Shigeo Suzuki
Masuko Suzuki
Shiro Shigeta
Kazuhiro Hirabayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Minophagen Pharmaceutical Co Ltd
Original Assignee
Minophagen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minophagen Pharmaceutical Co Ltd filed Critical Minophagen Pharmaceutical Co Ltd
Priority to JP21118187A priority Critical patent/JPS6452723A/en
Publication of JPS6452723A publication Critical patent/JPS6452723A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE:To obtain a suppressant against multiplication of AIDS virus, strongly suppressing multiplication of AIDS virus, showing inhibitory effects on degeneration of infected cell, containing mannan sulfuric ester and an alkali addition salt thereof as an active ingredient. CONSTITUTION:An mannan sulfuric ester shown by the formula (w, x, y and z are number of M (mannopyranosyl), the average value thereof is 2.2 and n is about 20; m is number of sulfate group and is 0-2; sulfate content of sulfated mannan is 1-20%) or a pharmaceutically acceptable salt thereof as an active ingredient is blended with a conventional excipient and pharmaceutically manufactured by a conventional procedure to give the aimed substance. The substance can be prepared into a dosage form such as powder, granule, sugar-coated tablet or capsule. A dose is 300mg per adult daily in the case of parenteral administration. The compound shown by the formula is well-known and is obtained by introducing sulfate group into mannan separated and purified from various kinds of yeast (e.g. beer yeast or baker's yeast).
JP21118187A 1987-08-24 1987-08-24 Suppressant against multiplication of aids virus Pending JPS6452723A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP21118187A JPS6452723A (en) 1987-08-24 1987-08-24 Suppressant against multiplication of aids virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21118187A JPS6452723A (en) 1987-08-24 1987-08-24 Suppressant against multiplication of aids virus

Publications (1)

Publication Number Publication Date
JPS6452723A true JPS6452723A (en) 1989-02-28

Family

ID=16601756

Family Applications (1)

Application Number Title Priority Date Filing Date
JP21118187A Pending JPS6452723A (en) 1987-08-24 1987-08-24 Suppressant against multiplication of aids virus

Country Status (1)

Country Link
JP (1) JPS6452723A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009181A1 (en) * 1989-02-10 1990-08-23 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
JP2007210908A (en) * 2006-02-07 2007-08-23 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Antiviral agent
JP2008266265A (en) * 2007-04-24 2008-11-06 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Antiviral agent

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990009181A1 (en) * 1989-02-10 1990-08-23 Taiho Pharmaceutical Co., Ltd. Anti-hiv drug
JP2007210908A (en) * 2006-02-07 2007-08-23 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Antiviral agent
JP2008266265A (en) * 2007-04-24 2008-11-06 Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Antiviral agent

Similar Documents

Publication Publication Date Title
GR3001284T3 (en) Pharmaceutical composition containing ibuprofen and aluminium hydroxide
AU1211992A (en) Low dose dry pharmaceutical preparations
DE69534745T2 (en) IMMUNOPOTENZATING 5'-NUCLEOTIDASE RESISTANT INOSINMONOPHOSPHATE DERIVATIVES AND THEIR USE
JPS6452723A (en) Suppressant against multiplication of aids virus
DE3873232T2 (en) A MEDICINAL PRODUCT CONTAINING DIDEOXYNUCLEOSIDE.
US5491150A (en) Supplementary therpeutic agents for the treatment of immunodeficiency syndrome
KR970705563A (en) (2-amino-6- (cyclopropylamino) -9H-purin-9-yl) -2-cyclopentene-1-methanol succinate -9H-Purin-9-yl) -2-cyclopentene-1-methanol Succinate as Antiviral Agent)
JPS6416721A (en) Antioxidant
US5102883A (en) Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
Wintergerst et al. Pharmacokinetics of orally administered zidovudine in HIV-infected children and adults
JPS55122715A (en) Antidiabetic agent
JPS5791922A (en) Antiviral agent of external use
US4391809A (en) Methods for treating psoriasis
JPS5793913A (en) Enhancing agent for spermous vital power
DiSanto et al. Comparative Bioavailability Evaluation of Erythromycin Base and Its Salts and Esters. I. Erythromycin Estolate Capsules Versus Enteric‐Coated Erythromycin Base Tablets
JPS57126422A (en) Stabilizing method of lysozyme pharmaceutical
JPS57179118A (en) Antitumor agent
JPS6425728A (en) Nootropic (noesis improving agent)
JPS6413026A (en) Antiviral agent
JPS5462327A (en) Remedy for dna virus infectious disease
JPS6442430A (en) Side effect remover for chemotherapeutic agent
EP0367509A3 (en) Formulations
CA2082495A1 (en) A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
Nottage et al. Effect of lithium on voluntary alcohol consumption by low and high preference mouse strains
JPH05301816A (en) Anti-AIDS agent